An interventional study of total hip arthroplasty in Hip Osteoarthritis and Surgery, sponsored by Orthopedic One. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-12-13.
Sponsored by Orthopedic One · Not applicable, Interventional, and Treatment
130 patients undergoing primary unilateral total hip arthroplasty through anterior approach were enrolled and randomized into one of two groups. One group received standard of care clinic-based physical therapy postoperatively (clinic PT) while the other group underwent progressive home-based exercises to do after surgery (home PT). Patient surveys with Hip Osteoarthritis Outcome Scores (HOOS) and SF12v2 scores for both groups were obtained before surgery as well as 6, 14, and 24 weeks postop. Patients had the option to crossover into the other study group at their 6-week follow-up visit.
628 studies on the registry are indexed under Osteoarthritis, Hip; 121 are open to participants now.
This study's enrollment of 130 is above the median of 90 across 450 interventional studies indexed under Osteoarthritis, Hip.
Browse Osteoarthritis, Hip studies →This is the only study on the registry with Orthopedic One as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: total hip arthroplasty
Procedure: total hip arthroplasty
each patient is expected to undergo an anterior total hip arthroplasty procedure and some sort of physical therapy postoperatively
Also known as: physical therapy
Change in Hip Disability and Osteoarthritis Outcome Scores
Time frame: preoperative, postoperative 6 weeks, postoperative 12 weeks, and postoperative 24 weeks
Change in SF-12v2 Scores
Time frame: preoperative and postoperative 24 weeks
Plan to share: No
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.